Idexx Laboratories IDXX Americas — Total consolidated revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Idexx Laboratories’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's americas — total consolidated revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Idexx Laboratories's americas — total consolidated revenue?
- Idexx Laboratories (IDXX) reported americas — total consolidated revenue of $752.63M in Q4 2025.
- How has Idexx Laboratories's americas — total consolidated revenue changed year-over-year?
- Idexx Laboratories's americas — total consolidated revenue increased by 8.7% year-over-year, from $692.44M to $752.63M.
- What is the long-term trend for Idexx Laboratories's americas — total consolidated revenue?
- Over 4 years (2021 to 2025), Idexx Laboratories's americas — total consolidated revenue has grown at a 8.1% compound annual growth rate (CAGR), from $2.2B to $3.01B.
- What does americas — total consolidated revenue mean?
- This metric represents the total gross income generated from the sale of diagnostic products, equipment, and veterinary services within the Americas geographic region. It reflects the market demand for animal health solutions and the effectiveness of the company's sales and distribution strategy in this specific territory. As a primary driver of top-line growth, it serves as a key indicator of the company's competitive position and market penetration in the North and South American veterinary sectors.